With the global coronavirus pandemic entering its third year, transmission of the Omicron variant (B.1.1.529) and its subvariants (B.2, B.3) appears to be waning, with local governments loosening public health restrictions. A majority of the US population is now estimated to be immune to SARS-CoV-2 through vaccination or natural infection, but experience and data suggest future emergence of new variants is likely, with unpredictable implications for current prevention and treatment strategies.
Browse the JAMA Network COVID-19 collection below, including Q&A's with NIAID's Anthony Fauci and Patient Information pages.
Conversations with Frontline Clinicians and Experts about the COVID-19 pandemic.